The inverse association between the presence of antibody to hepatitis B surface antigen and atopy in young adults

Korean Journal of Internal Medicine

Volumn 20, Issue 3, 2005, Pages 210-216

  Koh, Youngil I ^a   Choi, Inseon S ^a   Park, Chang Hwan ^a   Ahn, Jae Sook ^a   Ji, Seung Gyu ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Atopic; Hepatitis B virus; Infection; Skin tests

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; ATOPY; CELLULAR IMMUNITY; CONFIDENCE INTERVAL; DERMATOPHAGOIDES FARINAE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRICK TEST; RISK REDUCTION; SENSITIZATION; SKIN ALLERGY; SKIN MANIFESTATION; SKIN TEST; SOUTH KOREA; TH1 CELL;

EID: 28444443085     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.3.210     Document Type: Article

References (36)

1. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 320:271-277, 1989
2. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and alopic eczema: ISAAC. Lancet 351:1225-1232, 1998
3. Strachan DP. Hay fever, hygiene, and household size. BMJ 299:1259-1260, 1989
4. Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, Goudiaby A. Measles and atopy in Guinea-Bissau. Lancet 347:1792-1796, 1996
5. Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D'Amelio R. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 314:999-1003, 1997
6. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 275:77-79, 1997
7. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today 13:379-381, 1992
8. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 47:450-455, 1992
9. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60, 1995
10. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36, 1996
11. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 71:3236-3243, 1997
12. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025-3933, 1997
13. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18(Suppl 1):S20-S22, 2000
14. Akbar SM, Abe M, Masumoto T, Horiike N, Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol 30:755-764, 1999
15. Hoofnagle JH, Lindsay KL. Acute viral hepatitis. In: Drazen JM, Gill GN, Griggs RC, Kokko JP, Mandell GL, Powell DW, Schafer AI, eds. Cecil textbook of medicine. 21st ed. pp. 783-790, Philadelphia, WB Saunders, 2000
16. Koh YI, Choi IS, Lim H. Atopy may be related to exercise-induced bronchospasm in asthma. Clin Exp Allergy 32:532-536, 2002
17. Marinos G, Torre F, Chokshi S, Hussain M, Clarke BE, Rowlands DJ, Eddleston AL, Naoumov NV, Williams R. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 22:1040-1049, 1995
18. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, Chang TH, Chen DS. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens: implications for hepatitis B e antigen seroconversion. J Clin Invest 89:87-96, 1992
19. Lohr HF, Weber W, Schlaak J, Goergen B, Meyer zum Buschenfelde KH, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 22:61-68, 1995
20. Ji W, Wang HF, Feng CQ. Activation-induced cell death in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10. J Viral Hepat 8:30-33, 2001
21. Naoumov NV, Rossol S. Studies of interleukin-12 in chronic hepatitis B virus infection. J Viral Hepat 4(Suppl 2):87-91, 1997
22. Kocabas CN. Do hepatitis B virus carriers develop atopic diseases? Allergy 56:1100-1101, 2001
23. Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 110:381-387, 2002
24. Chung WK, Yoo JY, Sun HS, Lee HY, Lee IJ, Kim SM, Prince AM. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis 151:280-286, 1985
25. Sherlock S, Dooley J. Diseases of the liver and biliary system. p.293, Oxford, Blackwell, 2002
26. Gruber C, Nilsson L, Bjorksten B. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr Allergy Immunol 12:296-311, 2001
27. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155:111-117, 1995
28. Swain SL. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543-552, 1994
29. Guler ML, Gorham JD, Hsieh CS, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984-987, 1996
30. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178:2123-2130, 1993
31. Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brociek W, Michel FB. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract: II. prediction of efficacy of immunotherapy. J Allergy Clin Immunol 82:971-977, 1988
32. Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O'Malley PM, Penley KA, Altman NL. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 315:209-214, 1986
33. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J Infect Dis 175:674-677, 1997
34. Scrivener S, Yemaneberhan H, Zebenigus M, Tilahun D, Girma S, Ali S, McElroy P, Custovic A, Woodcock A, Pritchard D, Venn A, Britton J. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 358:1493-1499, 2001
35. Huang SL, Shiao G, Chou P. Association between body mass index and allergy in teenage girls in Taiwan. Clin Exp Allergy 29:323-329, 1999
36. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann HH. Skin test reactivity and number of siblings. BMJ 308:692-695, 1994